About: Advances in targeted therapies III

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Advances in targeted therapies III Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/bmj/periodical/ard/2001/volume_60
Title	Advances in targeted therapies III
has manifestation of work	http://hub.abes.fr/bmj/periodical/ard/2001/volume_60/issue_suppl3/m/print http://hub.abes.fr/bmj/periodical/ard/2001/volume_60/issue_suppl3/m/web
Date Copyrighted	2001
Rights	Annals of the Rheumatic Diseases
issue	suppl 3
is Is Part Of of	High efficiency gene transfer is an efficient way of defining therapeutic targets: a functional genomics approach Cytokine blockers in psoriatic arthritis Differential roles of Toll-like receptors in the elicitation of proinflammatory responses by macrophages “Stepping-up” from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate Treatment of active spondyloarthropathy with infliximab, the chimeric monoclonal antibody to tumour necrosis factor α Novel targets for interleukin 18 binding protein Role of cytokines in the innate immune response to intracellular pathogens New treatment options in ankylosing spondylitis: a role for anti-TNFα therapy Radiographic progression in rheumatoid arthritis: Does it reflect outcome? Does it reflect treatment? Oncostatin M in the anti-inflammatory response Updated consensus statement on tumour necrosis factor blocking agents for the treatment of rheumatoid arthritis and other rheumatic diseases (April 2001) Treatment of myelodysplastic syndrome with agents interfering with inhibitory cytokines The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages Advances in targeted therapies III Matrix metalloproteinase inhibitors in rheumatic diseases Successful treatment of a small cohort of patients with adult onset of Still's disease with infliximab: first experiences Biology of TACE inhibition Antagonising angiogenesis in rheumatoid arthritis Osteoprotegerin

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata